Skip to main content

Table 2 Effect of synthesized NPs on phosphoglucose isomerase (PGI) activity in a wide range of microbial pathogens

From: Biogenic selenium nanoparticles and selenium/chitosan-Nanoconjugate biosynthesized by Streptomyces parvulus MAR4 with antimicrobial and anticancer potential

Tested NPs

% Inhibition of PGI

E. coli

P. vulgaris

S. typhi

S. aureus

A. flavus

A. niger

Rhizoctonia sp.

C. albicans

NCh

30.0 ± 0.7

0.6 ± 0.01

35.1 ± 0.8

21.9 ± 0.7

31.7 ± 0.7

30.7 ± 0.7

6.8 ± 0.3

11.3 ± 0.4

SeNPs

30.9 ± 0.7

2.2 ± 0.1

5.0 ± 0.2

44.0 ± 0.8

6.7 ± 0.2

45.8 ± 0.8

48.9 ± 0.8

2.1 ± 0.2

Se/Ch-nanoconjugate

43.8 ± 0.9

82.4 ± 1.5

60.0 ± 1.2

53.3 ± 1.0

61.3 ± 1.3

26.1 ± 0.5

71.6 ± 1.4

1.4 ± 0.01